Drug and Medical Device Lawsuits

Jury says Johnson & Johnson improperly marketed Risperdal

A jury in Arkansas ruled that Johnson & Johnson officials used deceptive tactics to market antipsychotic drug Risperdal, misleading doctors about the drug’s risks and improperly marketing it for unapproved uses, Bloomberg reports.

The decision in Arkansas marks the third such jury verdict against Johnson & Johnson over allegations that the pharmaceutical giant concealed Risperdal’s risks and tricked Medicaid regulators into paying more than they should have for the medication.

Juries also decided against the company in Louisiana and South Carolina.

A total ...

continue reading...

Metal-on-metal hip implants recalled – New Zealand

An Australian newspaper reports that metal-on-metal hip implants are being recalled in New Zealand, following international reports that the devices have a high early failure rate.

According to “The Australian,” a some citizens are pursuing legal action against the device’s manufacturer, seeking compensation for pain, suffering and financial loss.

Similar legal actions are taking place in other countries against the manufacturers of metal-on-metal hip implants, including the United States.

The report says ...

continue reading...

Faulty hip joints were meant to be more durable

Ironically, a type of hip implant that’s prompted thousands of lawsuits was designed specifically to prevent the types of problems it’s allegedly causing on a wide scale, according to a report in “Arthritis Today.”The report mentions a study published in respected British medical journal “The Lancet,” which found that metal-on-metal artificial hip joints are far more likely to fail within five years than other ...

continue reading...

New J&J CEO involved in previous recall

A Newark Star-Ledger profile of Alex Gorsky, the new CEO of Johnson & Johnson, describes him as “the go-to man” during the company’s 1998 recall of Hismanal, an antihistamine that proved to have dangerous cardiovascular side effects.

Gorsky has succeeded previous chief executive officer William Weldon, who stepped down after a disastrous series of recalls. But the Star-Ledger mentions that some industry observers are questioning whether Gorsky played a part in marketing a hip implant that has generated thousands of lawsuits ...

continue reading...

Surgeon: hip implant concern only for metal-on-metal devices

A British surgeon who specializes in hip surgery writes that he’s heard from many patients who have received hip replacements, and are concerned about recent reports dealing with the hazards of metal-on-metal hip implants.

In a piece for “This is Nottingham,” Dr. Andrew Manktelow of Queen’s Medical Centre writes that most hip replacement patients have no need for concern.

“Most patients will have had either a metal or ceramic ball on a plastic liner or a ceramic on ceramic bearing. If you ...

continue reading...

Radiological devices had FDA whistle-blowers concerned

Six U.S. Food and Drug Administration doctors and scientists who claim the agency retaliated against them said they were trying to raise valid concerns about medical devices of unproven effectiveness, The Washington Post has reported.

The doctors and scientists, who worked in the office charged with reviewing medical devices, have filed suit in federal court alleging that the FDA monitored their personal e-mail accounts, and used information obtained that way to harass and improperly dismiss them.

According to The Washington Post, they ...

continue reading...
Page 130 of 139 «...100110120128129130131132...»